{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:26:02Z","timestamp":1792578362905,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012218","name":"jiangsu key laboratory of new drug research and clinical pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s40199-022-00432-0","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T13:12:51Z","timestamp":1647349971000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of the anticandidal activity of clotrimazole using Lactobacillus caseie ghosts as biological drug carrier"],"prefix":"10.1007","volume":"30","author":[{"given":"Touba","family":"Eslaminejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hassan","family":"Moshafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matineh","family":"Hasanpore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Amin","family":"Ayatollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0198-6604","authenticated-orcid":false,"given":"Mehdi","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"issue":"1","key":"432_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-020-01464-4","volume":"19","author":"WJY Chee","year":"2020","unstructured":"Chee WJY, Chew SY, Than LTL. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microb Cell Fact. 2020;19(1):1\u201324.","journal-title":"Microb Cell Fact"},{"issue":"3","key":"432_CR2","doi-asserted-by":"publisher","first-page":"e03619","DOI":"10.1016\/j.heliyon.2020.e03619","volume":"6","author":"S Farahyar","year":"2020","unstructured":"Farahyar S, et al. Low prevalence of antifungal resistant Candida africana, in the C. albicans complex causing vulvovaginal candidiasis. Heliyon. 2020;6(3):e03619.","journal-title":"Heliyon"},{"key":"432_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/B978-0-12-820576-1.00004-7","volume-title":"Combination therapy against multidrug resistance","author":"IK Maurya","year":"2020","unstructured":"Maurya IK, Semwal RB, Semwal DK. Combination therapy against human infections caused by Candida species. In: Combination therapy against multidrug resistance. Elsevier; 2020. p. 81\u201394."},{"issue":"1","key":"432_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/jof6010023","volume":"6","author":"SB Salazar","year":"2020","unstructured":"Salazar SB, et al. An overview on conventional and non-conventional therapeutic approaches for the treatment of candidiasis and underlying resistance mechanisms in clinical strains. J Fungi. 2020;6(1):23.","journal-title":"J Fungi"},{"key":"432_CR5","doi-asserted-by":"crossref","unstructured":"Dash P, Piras AM, Dash M. Cell membrane coated nanocarriers-an efficient biomimetic platform for targeted therapy. J Control Release. 2020.","DOI":"10.1016\/j.jconrel.2020.09.012"},{"key":"432_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-811924-2.00019-5","volume-title":"Mucosal vaccines","author":"JH Rhee","year":"2020","unstructured":"Rhee JH. Current and new approaches for mucosal vaccine delivery. In: Mucosal vaccines. Elsevier; 2020. p. 325\u201356."},{"key":"432_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1208\/s12249-020-01716-x","volume":"21","author":"GI Harisa","year":"2020","unstructured":"Harisa GI, et al. Bacteriosomes as a promising tool in biomedical applications: immunotherapy and drug delivery. AAPS PharmSciTech. 2020;21:168.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"432_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-62184-8","volume":"10","author":"MT Manhanzva","year":"2020","unstructured":"Manhanzva MT, et al. Inflammatory and antimicrobial properties differ between vaginal Lactobacillus isolates from South African women with non-optimal versus optimal microbiota. Sci Rep. 2020;10(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"1","key":"432_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-64705-x","volume":"10","author":"EF Oerlemans","year":"2020","unstructured":"Oerlemans EF, et al. impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome. Sci Rep. 2020;10(1):1\u201310.","journal-title":"Sci Rep"},{"key":"432_CR10","doi-asserted-by":"publisher","first-page":"105563","DOI":"10.1016\/j.ejps.2020.105563","volume":"156","author":"JA Silva","year":"2020","unstructured":"Silva JA, et al. Immobilization of vaginal Lactobacillus in polymeric nanofibers for its incorporation in vaginal probiotic products. Eur J Pharm Sci. 2020;156:105563.","journal-title":"Eur J Pharm Sci"},{"key":"432_CR11","doi-asserted-by":"crossref","unstructured":"Li W, Ma ZS. Dominance network analysis of the healthy human vaginal microbiome not dominated by Lactobacillus species. Comput Struct Biotechnol J. 2020.","DOI":"10.1016\/j.csbj.2020.10.033"},{"key":"432_CR12","doi-asserted-by":"crossref","unstructured":"Abdolalipour E, et al. Evaluation of the antitumor immune responses of probiotic Bifidobacterium bifidum in human papillomavirus-induced tumor model. Microbial Pathog. 2020;104207.","DOI":"10.1016\/j.micpath.2020.104207"},{"key":"432_CR13","doi-asserted-by":"crossref","unstructured":"Federici S, Nobs SP, Elinav E. Phages and their potential to modulate the microbiome and immunity. Cell Mol Immunol. 2020;1\u201316.","DOI":"10.1038\/s41423-020-00532-4"},{"key":"432_CR14","doi-asserted-by":"crossref","unstructured":"Jackson M, et al. Transporters involved in the biogenesis and functionalization of the mycobacterial cell envelope. Chem Rev. 2020.","DOI":"10.1021\/acs.chemrev.0c00869"},{"issue":"3","key":"432_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2174\/1566523220999200731011702","volume":"20","author":"S Agarwal","year":"2020","unstructured":"Agarwal S, et al. Exosomes: structure, biogenesis, types and application in diagnosis and gene and drug delivery. Curr Gene Ther. 2020;20(3):195\u2013206.","journal-title":"Curr Gene Ther"},{"key":"432_CR16","doi-asserted-by":"crossref","unstructured":"Moradi M, Molaei R, Guimar\u00e3es JT. A review on preparation and chemical analysis of postbiotics from lactic acid bacteria. Enzyme Microbial Technol. 2020;109722.","DOI":"10.1016\/j.enzmictec.2020.109722"},{"key":"432_CR17","doi-asserted-by":"crossref","unstructured":"Batah AM, Ahmad TA. The development of ghosts vaccine trials. Expert Rev Vaccines. 2020.","DOI":"10.1080\/14760584.2020.1777862"},{"issue":"10","key":"432_CR18","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1080\/03639045.2020.1820039","volume":"46","author":"FK Alanazi","year":"2020","unstructured":"Alanazi FK, et al. Vision of bacterial ghosts as drug carriers mandates accepting the effect of cell membrane on drug loading. Drug Dev Ind Pharm. 2020;46(10):1716\u201325.","journal-title":"Drug Dev Ind Pharm"},{"key":"432_CR19","doi-asserted-by":"crossref","unstructured":"Cao S-L, et al. Impacts of oral Vibrio mimicus double-targeted DNA vaccine on the gut microbiota in grass carps (Ctenopharyngodon idella) and correlations with intestinal mucosa innate immunity. Aquaculture. 2020;736201.","DOI":"10.1016\/j.aquaculture.2020.736201"},{"issue":"1","key":"432_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-020-00867-w","volume":"51","author":"S Soleymani","year":"2020","unstructured":"Soleymani S, et al. Design, development, and evaluation of the efficacy of a nucleic acid-free version of a bacterial ghost candidate vaccine against avian pathogenic E. coli (APEC) O78: K80 serotype. Vet Res. 2020;51(1):1\u201316.","journal-title":"Vet Res"},{"key":"432_CR21","doi-asserted-by":"publisher","first-page":"545741","DOI":"10.1155\/2013\/545741","volume":"2013","author":"AA Amara","year":"2013","unstructured":"Amara AA, Salem-Bekhit MM, Alanazi FK. Sponge-like: a new protocol for preparing bacterial ghosts. Sci World J. 2013;2013:545741.","journal-title":"Sci World J"},{"key":"432_CR22","doi-asserted-by":"crossref","unstructured":"Xie S, et al. Bacterial ghosts for targeting delivery and subsequent responsive release of ciprofloxacin to destruct intracellular bacteria. Chem Eng J. 2020;125700.","DOI":"10.1016\/j.cej.2020.125700"},{"issue":"10","key":"432_CR23","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jsps.2020.08.016","volume":"28","author":"S Rabea","year":"2020","unstructured":"Rabea S, et al. Salmonella-innovative targeting carrier: Loading with doxorubicin for cancer treatment. Saudi Pharm J. 2020;28(10):1253\u201362.","journal-title":"Saudi Pharm J"},{"key":"432_CR24","doi-asserted-by":"publisher","first-page":"117012","DOI":"10.1016\/j.carbpol.2020.117012","volume":"250","author":"E Cetindag","year":"2020","unstructured":"Cetindag E, et al. Effect of solvents and cellulosic polymers on quality attributes of films loaded with a poorly water-soluble drug. Carbohydr Polymers. 2020;250:117012.","journal-title":"Carbohydr Polymers"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-022-00432-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-022-00432-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-022-00432-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T14:59:54Z","timestamp":1652799594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-022-00432-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["432"],"URL":"https:\/\/doi.org\/10.1007\/s40199-022-00432-0","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"12 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author reports no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}